SA

Sandhya Ajan

Active Director Director DIN 03072558
DIN 03072558 First appointment Jul 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2010
Shareholding value •••• Premium profile

About Sandhya Ajan

Data last updated:

Sandhya Ajan is a Director at A S Pharmaceutical (India) Private Limited (since 2010). The company operates in Pharma. A S Pharmaceutical (India) Private Limited reported revenue of ₹79 Lakh (FY 2024).

DIN 03072558
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2010
Oldest Company Age 16 yrs
Largest company A S Pharmaceutical (India) Private Limited · ₹79 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20102010₹79 Lakh (FY 2024)Active

Board colleagues of Sandhya Ajan

Directorship timeline

Open interactive timeline →
A S Pharmaceutical (India) Private Limited
Premium access

Shareholding and investment profile for Sandhya Ajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandhya Ajan

Sandhya Ajan currently holds 1 directorship: A S Pharmaceutical (India) Private Limited (Director, since 21 Jul 2010, revenue ₹79 Lakh (FY 2024)).

Sandhya Ajan was first appointed on 21 Jul 2010 as Director at A S Pharmaceutical (India) Private Limited.

The current boards of Sandhya Ajan's companies include Gopinathan Nair Ajan (A S Pharmaceutical (India) Private Limited), Raghavendra Gowdaiahnadoddi (A S Pharmaceutical (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available